[1]
“TCA as an effective augmentation therapy in case of resistant and recurrent tinea cruris & corporis”, JOC, vol. 24, no. 9s, pp. 78–86, Oct. 2025, doi: 10.64149/J.Carcinog.24.9s.78-86.